Latest Breaking News On - European excellence centre - Page 1 : comparemela.com

Mundipharma announces European approval of REZZAYO (rezafungin) for the treatment of Invasive Candidiasis in adults

Mundipharma announces European approval of REZZAYO (rezafungin) for the treatment of Invasive Candidiasis in adults
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesAntimicrob chemotherOliver cornelyStefan klotterAsia pacificYuri martinaCommittee for medicinal products human useEuropean unionCommunity registerUniversity hospital cologneEuropean commissionCidara therapeutics incData review committeeFor tradeMedical mediaMedicinal products

Cidara Therapeutics (CDTX) Announces EU Approval of REZZAYO

Cidara Therapeutics (CDTX) Announces EU Approval of REZZAYO
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesTaylor sandisonOliver cornelyCidara therapeutics incData review committeeCommittee for medicinal products human useEuropean commissionEuropean unionUniversity hospital cologneCidara therapeuticsMedicinal productsHuman useEuropean excellence centreMedical mycologyEuropean commissionmarksChief medical officer

Mundipharma announces European approval of REZZAYO® (rezafungin) for the treatment of Invasive Candidiasis in adults

Mundipharma announces European approval of REZZAYO® (rezafungin) for the treatment of Invasive Candidiasis in adults
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesAsia pacificOliver cornelyYuri martinaAntimicrob chemotherCommittee for medicinal products human useData review committeeEuropean unionUniversity hospital cologneEuropean commissionCidara therapeutics incCommunity registerFor tradeMedical mediaMedicinal products

Cidara Therapeutics Announces European Approval Of REZZAYO® (Rezafungin) For The Treatment Of Invasive Candidiasis In Adults

Cidara Therapeutics Announces European Approval Of REZZAYO® (Rezafungin) For The Treatment Of Invasive Candidiasis In Adults
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesBrian ritchieVeronica eamesOliver cornelyTaylor sandisonLifesci communicationsCidara therapeutics incUniversity hospital cologneSecurities exchangeData review committeeEuropean commissionEuropean unionCommittee for medicinal products human useExchange commissionEuropean medicines agency

Mundipharma announces European approval of REZZAYO® (rezafungin) for the treatment of Invasive Candidiasis in adults

Mundipharma today announced rezafungin (rezafungin acetate) has been approved in the European Union (EU) for the treatment of invasive candidiasis in adults. The approval by the European Commission (EC) follows the positive opinion of the Committee.

United statesYuri martinaAsia pacificOliver cornelyAntimicrob chemotherProduct serviceUniversity hospital cologneCommunity registerEuropean unionData review committeeEuropean commissionCommittee for medicinal products human useCidara therapeutics incInvasive candidiasisMedicinal productsHuman use